Friday, September 16, 2016

Diprobath





1. Name Of The Medicinal Product



Diprobath


2. Qualitative And Quantitative Composition



Light Liquid Paraffin 46.0% w/w



Isopropyl Myristate 39.0% w/w



For a full list of excipients, see section 6.1.



3. Pharmaceutical Form



Liquid bath emollient



4. Clinical Particulars



4.1 Therapeutic Indications



Treatment of dry skin conditions and other hyperkeratoses, including those associated with dermatitis and eczema.



To be diluted in bath water for external application.



4.2 Posology And Method Of Administration



Adults including elderly patients :



25ml or approximately 2.5 capsful to be diluted in a bath of water (100 L approximately). For particularly dry skin the quantity of oil emollient may be doubled.



Children :



10ml or one capful is sufficient for children's baths.



Frequency and duration of bathing will depend on the type and severity of the conditions, but generally 2 to 3 baths should be taken weekly.



4.3 Contraindications



Known hypersensitivity to any of the ingredients.



4.4 Special Warnings And Precautions For Use



As Diprobath deposits a film of oil over the skin, care should be taken to avoid slipping in the bath.



The following warning will appear on the label :



'Take care when entering or leaving the bath which may be more slippery than usual'.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



No special precautions.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



None known.



4.9 Overdose



Not applicable.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Both active ingredients have established emollient properties which are of relevance to use as a bathing emollient.



5.2 Pharmacokinetic Properties



Pharmacokinetic principles are not involved due to direct topical application.



5.3 Preclinical Safety Data



There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Laureth-4



6.2 Incompatibilities



None Known



6.3 Shelf Life



24 months



6.4 Special Precautions For Storage



Store upright at a temperature below 30°C.



6.5 Nature And Contents Of Container



50 ml and 500 ml: natural opaque high-density polyethylene (HDPE) single neck bottle with a polypropylene screw cap. Mounted in the cap is a polyethylene liner containing a polytetrafluoroethylene (PTFE) venting disc.



Not all pack sizes may be marketed.



6.6 Special Precautions For Disposal And Other Handling



Not applicable



7. Marketing Authorisation Holder



Merck Sharp & Dohme Limited



Hertford Road



Hoddesdon



Hertfordshire



EN11 9BU



UK



8. Marketing Authorisation Number(S)



PL 00025/0584



9. Date Of First Authorisation/Renewal Of The Authorisation



11 November 1991 / 10 January 2007



10. Date Of Revision Of The Text



19 January 2011



11 LEGAL CATEGORY


P



© Merck Sharp & Dohme Limited 2011. All rights reserved.



Diprobath UK/01-11/5




No comments:

Post a Comment